1. Home
  2. BROS vs LNTH Comparison

BROS vs LNTH Comparison

Compare BROS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dutch Bros Inc.

BROS

Dutch Bros Inc.

N/A

Current Price

$42.00

Market Cap

8.5B

ML Signal

N/A

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

N/A

Current Price

$100.60

Market Cap

6.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BROS
LNTH
Founded
1992
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
6.6B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BROS
LNTH
Price
$42.00
$100.60
Analyst Decision
Strong Buy
Buy
Analyst Count
20
6
Target Price
$76.40
$87.00
AVG Volume (30 Days)
3.7M
1.1M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
88.24
N/A
EPS
0.41
2.91
Revenue
$1,638,159,000.00
$343,374,000.00
Revenue This Year
$27.34
N/A
Revenue Next Year
$23.01
$14.19
P/E Ratio
$107.07
$34.48
Revenue Growth
27.88
3.62
52 Week Low
$43.29
$49.67
52 Week High
$74.02
$111.86

Technical Indicators

Market Signals
Indicator
BROS
LNTH
Relative Strength Index (RSI) 30.35 43.86
Support Level N/A $99.80
Resistance Level $59.07 $101.43
Average True Range (ATR) 1.72 0.49
MACD -0.04 0.06
Stochastic Oscillator 9.55 12.94

Price Performance

Historical Comparison
BROS
LNTH

About BROS Dutch Bros Inc.

Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies, and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company-operated shops.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: